Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood-brain barrier.

Autor: Hauptmann J; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Johann L; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Marini F; Center of Thrombosis and Hemostasis Mainz (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Kitic M; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Colombo E; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Mufazalov IA; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Krueger M; Anatomical Institute, University of Leipzig, Leipzig, Germany., Karram K; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Moos S; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Department of Dermatology, Heidelberg University Hospital, 69120, Heidelberg, Germany., Wanke F; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area Roche Innovation Center, Basel, Switzerland., Kurschus FC; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Department of Dermatology, Heidelberg University Hospital, 69120, Heidelberg, Germany., Klein M; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Cardoso S; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Strauß J; Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany., Bolisetty S; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany., Lühder F; Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany., Schwaninger M; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany., Binder H; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany., Bechman I; Anatomical Institute, University of Leipzig, Leipzig, Germany., Bopp T; Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Agarwal A; Nephrology Research and Training Center, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Soares MP; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Regen T; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. regen@uni-mainz.de., Waisman A; Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. waisman@uni-mainz.de.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. waisman@uni-mainz.de.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2020 Oct; Vol. 140 (4), pp. 549-567. Date of Electronic Publication: 2020 Jul 11.

Waldeyer Anatomie de Menschen 17. Auflage

Autor: Anderhuber, F:Bade, H, Bechman, I, Beck, Th, Brehmer, A, Fanghaenel, J:Filler, T.J, Funk, R.H.W.:Giebel, J, Kocher, Th, Koebke, J, Koppe, Th, Kubein-Meesenburg, D, Lemke, C, Linss, W, Maurer, H, Miehe, B, Naegerl, H, Nitsch, R, Pera, F, Peuker, E.T., Prescher, A, Reiss, G, Schmidt, H.-M, Schmiedebach, H.-P, Schulte, E, Splieth, Chr, Weingaertner J.

Sustavna, topografska i klinička anatomija čovjeka

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9f95b2cd7c08e7af94925c48f6e869ee
https://www.bib.irb.hr/450990

The impairment of intramural periarterial drainage in brain after subarachnoid hemorrhage.

Autor: Sun, Yanrong¹ (AUTHOR), Liu, E.^1,2 (AUTHOR), Pei, Yanhong¹ (AUTHOR), Yao, Qinhan¹ (AUTHOR), Ma, Haowen¹ (AUTHOR), Mu, Yakun¹ (AUTHOR), Wang, Yingjie¹ (AUTHOR), Zhang, Yan¹ (AUTHOR), Yang, Xiaomei¹ (AUTHOR), Wang, Xing³ (AUTHOR), Xue, Jiajia³ (AUTHOR), Zhai, Jiliang⁴ (AUTHOR), Carare, Roxana O.^5,6 (AUTHOR) R.O.Carare@soton.ac.uk, Qin, Lihua¹ (AUTHOR) qinlihua88@bjmu.edu.cn, Yan, Junhao^1,7 (AUTHOR) yjh@bjmu.edu.cn

Publikováno v: Acta Neuropathologica Communications. 12/18/2022, Vol. 10 Issue 1, p1-18. 18p.

N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer's pathophysiology.

Autor: Rostagno, Agueda^1,2 (AUTHOR), Cabrera, Erwin^1,2,3 (AUTHOR), Lashley, Tammaryn^4,5 (AUTHOR), Ghiso, Jorge^1,2 (AUTHOR) jorge.ghiso@nyumc.org

Publikováno v: Translational Neurodegeneration. 6/1/2022, Vol. 11, p1-18. 18p.

The glymphatic hypothesis: the theory and the evidence.

Autor: Hladky, Stephen B.¹ (AUTHOR) sbh1@cam.ac.uk, Barrand, Margery A.¹ (AUTHOR)

Publikováno v: Fluids & Barriers of the CNS. 2/3/2022, Vol. 19 Issue 1, p1-33. 33p.